Henry Ford Health System
Also known as: Benjamin Movsas, M.D. | Chang, Steve S., M.D. | Clinic 10 - Henry Ford Hospital | Department of Dermatology, Henry Ford Hospital | Henry Ford | Henry Ford Dermatology | Henry Ford Health | Henry Ford Health System | Henry Ford Health System: Division of Allergy and Immunology | Henry Ford Health Systems | Henry Ford Health Systems - Department of Dermatology | Henry Ford Health Systems Dermatology Department | Henry Ford Health Systems, Franklin Pointe Medical Center | Henry Ford Health System Sleep Disorders Ctr | Henry Ford Hospital | Henry Ford Hospital, 3031 W. Grand Blvd., Suite 800, Detroit, MI 48202, USA | Henry Ford Hospital Department of Orthopaedic Surgery | Henry Ford Hospital, Sleep Disorders and Research Center | Henry Ford Hospital, USA, MI | Henry Ford Hospital - West Bloomfield | Henry Ford HS | Henry Ford Medical Center-New Center One, Detroit, MI | Henry Ford Medical Center, USA | Josephine Ford Cancer Center | Quan Jiang | Shaheen Alanee | Shirish Gadgeel | Sleep Disorders and Research Center, Henry Ford Hospital | Steve S. Chang, M.D. | The Henry Ford Hospital | The Henry Ford Hospital, Detroit, MI 48202
Highest phase reached
Phase 4
First clinical trial
Oct 1, 1974Last known activity
Dec 1, 2025
Timeline
1910s
- Jan 1, 1915
Henry Ford Health System— Founded
Drugs by trial phase (165 distinct, 142 trials)
Phase 4 (54 own, 0 via acquisition)
Phase 3 (33 own, 0 via acquisition)
Phase 2 (41 own, 0 via acquisition)
Phase 1 (18 own, 0 via acquisition)
Indications
Studied for
- Abdominal Pain
- Acne Vulgaris
- Acquired Immunodeficiency Syndrome
- Acute Coronary Syndrome
- Adenocarcinoma
- Adenoviridae Infections
- Aneurysm
- Anterior Cruciate Ligament Injuries
- Arthritis
- Arthritis, Gouty
- Arthritis, Infectious
- Asthma
- Ataxia
- Back Pain
- Bacteremia
- Blood Loss, Surgical
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Cardiovascular Diseases
- Cellulitis
- Cerebral Hemorrhage
- Cerebral Infarction
- Clostridium Infections
- Colorectal Neoplasms
- Communicable Diseases
- Constriction, Pathologic
- Coronary Disease
- Coronavirus Infections
- Cystitis
- Cystitis, Interstitial
- Death, Sudden
- Death, Sudden, Cardiac
- Delayed Emergence from Anesthesia
- Delirium
- Endocarditis
- Fibromyalgia
- Fibrosis
- Gait Disorders, Neurologic
- Glioblastoma
- Glioma
- Gliosarcoma
- Gout
- Head and Neck Neoplasms
- Healthcare-Associated Pneumonia
- Heart Diseases
- Heart Failure
- Hemorrhage
- HIV Infections
- Hyperparathyroidism
- Hyperparathyroidism, Secondary
- Hyperplasia
- Hypertension
- Hypertrophy
- Idiopathic Pulmonary Fibrosis
- Infarction
- Infections
- Influenza, Human
- Intracranial Aneurysm
- Ischemia
- Kidney Diseases
- Liver Diseases
- Low Back Pain
- Lung Diseases, Interstitial
- Lung Neoplasms
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Myocardial Infarction
- Myocardial Ischemia
- Myofascial Pain Syndromes
- Nausea
- Neoplasm Metastasis
- Neoplasms
- Nervous System Diseases
- Oropharyngeal Neoplasms
- Osteoarthritis, Hip
- Osteoarthritis, Knee
- Osteomyelitis
- Pancreatic Neoplasms
- Parkinson Disease
- Pneumonia
- Pneumonia, Pneumocystis
- Postoperative Nausea and Vomiting
- Postoperative Pain
- Prostatic Hyperplasia
- Prostatic Neoplasms
- Psoriasis
- Pulmonary Fibrosis
- Renal Insufficiency, Chronic
- Rotator Cuff Injuries
- Sarcoidosis
- Severe Acute Respiratory Syndrome
- Skin Diseases
- Skin Diseases, Infectious
- Sleep Initiation and Maintenance Disorders
- Spinal Stenosis
- Staphylococcal Skin Infections
Recent trials (50)
- NCT07136415CollaboratorPhase 4Dec 1, 2025
- NCT07076082CollaboratorPhase 4Oct 15, 2025
- NCT06865339CollaboratorPhase 2Aug 7, 2025
- NCT06948552Sponsor investigatorPhase 2May 31, 2025
- NCT06948552Lead sponsorPhase 2May 31, 2025
- NCT06802224CollaboratorPhase 4Mar 1, 2025
- NCT06065371Lead sponsorPhase 1Feb 29, 2024
- NCT06065371Reponsible party - principal investigatorPhase 1Feb 29, 2024
- NCT07037888Lead sponsorPhase 4Dec 13, 2023
- NCT07037888Sponsor investigatorPhase 4Dec 13, 2023
- NCT04684212Overall official - principal investigatorN/ADec 1, 2023
- NCT04684212OfficialN/ADec 1, 2023
- NCT04684212Sponsor investigatorN/ADec 1, 2023
- NCT04684212Lead sponsorN/ADec 1, 2023
- NCT05766683Lead sponsorPhase 1Mar 14, 2023
Details
- Founded
- Detroit, MI, US Jan 1, 1915
- Last known activity
- Dec 1, 2025